SS
VOR icon

SBI Securities’s Vor Biopharma VOR Stock Holding History

SBI Securities’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$55 Hold
3
– – ﹤0.01% 3647
2026
Q1 		$54 Hold
3
– – ﹤0.01% 3561
2025
Q4 		$39 Hold
3
– – ﹤0.01% 3629
2025
Q3 		$146 Sell
3
-17
-85% -$684 ﹤0.01% 3413
2025
Q2 		$648 Buy
20
+13
+186% +$115 ﹤0.01% 2856
2025
Q1 		$95 Sell
7
-17
-71% -$408 ﹤0.01% 3458
2024
Q4 		$534 Buy
+24
New +$398 ﹤0.01% 2870

Other funds holding VOR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
AI
Axiom Investors Greenwich, Connecticut $11.6B AUM 69.67% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

SBI Securities's VOR Position: Q2 2026 in Review

SBI Securities held its Vor Biopharma (VOR) position steady in Q2 2026 at 3 shares worth $55. The position accounts for ﹤0.01% of the portfolio, ranked #3647.

SBI Securities first reported a position in VOR in Q4 2024 and has held it in 7 quarters since. The position peaked at $648 in Q2 2025. 43 funds tracked by Wall St. Rank hold VOR as of Q2 2026.

  • SBI Securities held 3 shares of Vor Biopharma worth $55 as of Q2 2026.
  • SBI Securities left its Vor Biopharma share count unchanged in Q2 2026.
  • Vor Biopharma made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3647 holding.
  • SBI Securities first reported a position in Vor Biopharma in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Vor Biopharma position peaked at $648 in Q2 2025.
  • 43 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.